Article
Epidermal growth factor receptor mutations in lung cancer.
Nature reviews. Cancer - 1 Mar 2007
Sharma Sreenath V, Bell Daphne W, Settleman Jeffrey, Haber Daniel A
Abstract excerpt
The development and clinical application of inhibitors that target the epidermal growth factor receptor (EGFR) provide important insights for new lung cancer therapies, as well as for the broader field of targeted cancer therapies. We review the results of genetic, biochemical and clinical studies focused on somatic mutations of EGFR that are associated with the phenomenon of oncogene addiction, describing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
